We have observed
11 EP applications
Andrew John Wright
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 10, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5
DELIVERY OF COATED HYDROPHOBIC ACTIVE AGENT PARTICLES
DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES
VACCINE ADJUVANT COMPOSITION COMPRISING INULIN PARTICLES
CODON SIGNATURE FOR NEUROMYELITIS OPTICA
Oxidized cardiolipin as a novel pro-inflammatory factor
NANOPARTICLE FORMULATIONS WITH ENHANCED MUCOSAL PENETRATION
Muc-1 cytoplasmic domain peptides as inhibitors of cancer
METHOD AND SYSTEM FOR ELECTRO-ASSISTED HYDROGEN PRODUCTION FROM ORGANIC MATERIAL
SOLID DOSAGE FORM